Search

everythinglearnresearchcommunity

for

Search:↓

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Minoxidil use increases facial hair growth in females, more in older users.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.